Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial

Table 1

Demographic summary.

	Lafutidine (𝑁=99)	Rabeprazole (𝑁=95)
Gender
Males, 𝑛 (%)	62 (62.63)	53 (53.54)
Females, 𝑛 (%)	37 (37.37)	41 (41.41)
Age (years)
Mean ± SD	39.24 ± 11.82	40.47 ± 12.13
Median	38	38
Range	18–66	20–74
Weight (Kg)
Mean ± SD	59.48 ± 10.36	61.43 ± 9.76
Median	59	60.5
Range	38–85	40–90
Symptoms (score ≥4 at baseline)
Epigastric pain, 𝑛 (%)	89 (89.89)	80 (84.21)
Heartburn, 𝑛 (%)	96 (96.96)	93 (97.89)
Abdominal pain, 𝑛 (%)	90 (90.9)	80 (84.21)